Minoxidil Biorga 5% is indicated in cases of hair loss or weakening of the hair on the top of the head or in cases of generalized weakening of the hair.
It is a peripheral vasodilator, and therefore is indicated in adults aged between 18 and 65 years.
Contact your doctor if you do not notice any improvement or if you notice a worsening of the symptoms after 4 months.
It is not indicated in cases of alopecia areata (sudden or unexplained hair loss) or cicatricial alopecia (associated with skin with healing characteristics, such as a burn or an ulcer). Furthermore, it should not be used if the hair loss is associated with pregnancy, childbirth or serious conditions, such as thyroid dysfunction, lupus, hair loss associated with inflammation of the scalp or other conditions.
If you are pregnant, think you may be pregnant or are planning to become pregnant, or if you are breast-feeding, you should ask your doctor or pharmacist for advice before using this medicine.
Its mode of action involves the regulation of the biological cycles of the hair, prolonging the Anagen growth phase and minimizing the passive Telogen and Catagen phases.
Active ingredients
Minoxidil 50 mg/ml (5% w/v). One spray of 5% cutaneous solution of Minoxidil Biorga contains 7 mg of minoxidil. Seven sprays are required to apply approximately 1 ml of solution containing 50 mg minoxidil.
Excipients
Propylene glycol, ethanol 96%, purified water.
Directions for use
The dose of 1 ml should be applied to the scalp twice a day (once in the morning and once in the evening). The total daily dose should not exceed 2 ml.
ILCLOSED LEAFLET
Product images are purely indicative and may differ in graphics, size or content . Even the names of the products, the ingredients and the percentages described are purely indicative and the manufacturing companies could make changes or updates. The only element of identification is the ministerial code MINSAN. Pharmaserena declines all responsibility for any errors, omissions or lack of product updates.